Trang chủ › Ung thư tuyến tiền liệt › Illinois › Chicago
Thử nghiệm lâm sàng cho Ung thư tuyến tiền liệt tại Chicago, IL
45 nghiên cứu cho Ung thư tuyến tiền liệt đang tìm kiếm người tham gia tại các cơ sở ở Chicago và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Đang tuyểnGiai đoạn 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Đang tuyểnGiai đoạn 2
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
WATER IV PCa (AS Sub-study)
Đang tuyển
- University of Chicago, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Đang tuyểnGiai đoạn 1
- University of Chicago Hospital, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- và 1 nữa
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Đang tuyểnGiai đoạn 3
- Northwestern University, Chicago
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Đang tuyểnGiai đoạn 3
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 1
- University of Illinois Hospital & Health Sciences System, Chicago
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Đang tuyểnGiai đoạn 3
- Rush University Medical Center-Hematology and Oncology ( Site 0028), Chicago
- University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063), Chicago
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Đang tuyểnGiai đoạn 1
- University of Chicago Medical Center, Chicago
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Đang tuyểnGiai đoạn 2
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 2
- University of Illinois Cancer Center, Chicago
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Đang tuyểnGiai đoạn 3
- Northwestern University, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Đang tuyểnGiai đoạn 3
- University of Illinois Chicago, Chicago
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Research Site, Chicago
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Đang tuyểnGiai đoạn 3
- Research Site, Chicago
- Research Site, Chicago
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Đang tuyểnGiai đoạn 3
- Northwestern University, Chicago
- University of Illinois Cancer Center at Chicago, Chicago
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Đang tuyểnGiai đoạn 3
- Research Site, Chicago
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Đang tuyểnGiai đoạn 2
- Northwestern University, Chicago
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 3
- Rush University Medical Center, Chicago
- University of Illinois, Chicago
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Đang tuyểnGiai đoạn 1/2
- Research Site, Chicago
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Đang tuyểnGiai đoạn 2/3
- University of Chicago, Chicago
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Đang tuyểnGiai đoạn 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Đang tuyểnGiai đoạn 1/2
- University of Chicago, Chicago
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Đang tuyểnGiai đoạn 3
- Rush MD Anderson, Chicago
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Đang tuyểnGiai đoạn 3
- University of Illinois, Chicago
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Đang tuyểnGiai đoạn 1 sớmChào đón tình nguyện viên khỏe mạnh
- Northwestern University, Chicago
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
Đang tuyểnGiai đoạn 2
- UChicago Medicine Comprehensive Cancer Center, Chicago
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Đang tuyểnNghiên cứu quan sát
- University of Illinois at Chicago, Chicago
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago, Chicago
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Northwestern, Chicago
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1/2
- Rush University, Chicago
Clinical Trial of Approaches to Prostate Cancer Surgery
Đang tuyển
- Northwestern University, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Đang tuyểnGiai đoạn 1/2
- University of Chicago Medical Center, Chicago
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
Đang tuyển
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
GU-01: Glycyrrhizin in Prostate Cancer
Đang tuyểnGiai đoạn 2
- University of Illinois, Chicago
PSMA PET for Surveillance After Focal Therapy
Đang tuyển
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Đang tuyểnGiai đoạn 1
- The University of Chicago Comprehensive Cancer Center, Chicago
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
Đang tuyểnNghiên cứu quan sát
- The University of Chicago, Hyde Park · Cách 5 dặm
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Đang tuyểnGiai đoạn 4
- University of Chicago Medical Center, Chicago
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Đang tuyểnGiai đoạn 3
- Northwestern University, Chicago
- University of Illinois, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Đang tuyểnNghiên cứu quan sát
- Massive Bio SYNERGY-AI site, Chicago
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
Đang tuyển
- The University of Illinois at Chicago (UIC), Chicago
- UChicago Medicine Comprehensive Cancer Center, Chicago
Geriatric Assessment and Technology Evaluation in Prostate Cancer
Đang tuyểnNghiên cứu quan sát
- o University of Chicago Medicine Comprehensive Cancer Center, Chicago
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
Đang tuyểnGiai đoạn 4
- University of Chicago Medical Center, Chicago
Thử nghiệm cho Ung thư tuyến tiền liệt tại các thành phố khác
- New York City, NY101 nghiên cứu
- Houston, TX73 nghiên cứu
- Los Angeles, CA64 nghiên cứu
- Boston, MA56 nghiên cứu
- Seattle, WA45 nghiên cứu
- St. Louis, MO45 nghiên cứu
- Baltimore, MD45 nghiên cứu
- San Francisco, CA44 nghiên cứu
- Philadelphia, PA41 nghiên cứu
- Nashville, TN40 nghiên cứu
- Washington, DC39 nghiên cứu
- Dallas, TX39 nghiên cứu
Các nghiên cứu khác tại Chicago
- Ung thư vú59 nghiên cứu
- Ung thư phổi không tế bào nhỏ59 nghiên cứu
- Ung thư (mọi loại)51 nghiên cứu
- Ung thư phổi43 nghiên cứu
- Ung thư di căn42 nghiên cứu
- Béo phì40 nghiên cứu
- Ung thư buồng trứng36 nghiên cứu
- Ung thư đại trực tràng32 nghiên cứu
- Đột quỵ31 nghiên cứu
- Ung thư biểu mô tế bào vảy ở đầu và cổ29 nghiên cứu
- Thừa cân29 nghiên cứu
- Suy tim28 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 15 thg 11, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.